Sangamo Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 41 U.S.-traded ETFs. SGMO has around 12.5M shares in the U.S. ETF market. The largest ETF holder of SGMO is the SPDR S&P Biotech ETF (XBI), with approximately 4.31M shares. Investors may also find of interest that the ETF with the largest allocation to SGMO stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 1.79%. On average, U.S. ETFs allocate 0.18% of SGMO to their portfolios.
Additionally, SGMO is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with SGMO as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 50.29%.